FeNO as a Marker of Allergic Reactions to OFC and Response of OMA Treatment in Multiple FA
Public ClinicalTrials.gov record NCT06437171. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Use of Exhaled Nitric Oxide as a Predictive Marker of Allergic Reactions to Oral Food Challenge and Clinical Response of Omalizumab Treatment in Subjects With Multiple Food Allergies
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase IV, open-label, single-center study to evaluate the change in FeNO as a marker of clinical response to OMA in participants with multiple FA.
Study identification
- NCT ID
- NCT06437171
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 20 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2, 2024
- Primary completion
- Jun 30, 2026
- Completion
- Nov 30, 2026
- Last update posted
- Aug 13, 2025
2024 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AAADRS Clinical Research Center | Coral Gables | Florida | 33134 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Food Allergy trials
Other public records listing Food Allergy. Sorted by last update posted; newest first. Not a recommendation.
- NCT03539692: Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site Recruiting
- NCT04798079: Systems Biology of Early Atopy Active, not recruiting
- NCT02504853: Natural History and Genetics of Food Allergy and Related Conditions Recruiting
- NCT07321522: Early Introduction and Sustained Ingestion (EISI) Using Two Educational Opportunities in Infants Not yet recruiting
- NCT06369467: Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy Recruiting
- NCT06943534: Omalizumab Weight-Based Dosing Efficacy Trial Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06437171, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2025 · Synced Jul 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06437171 live on ClinicalTrials.gov.